The Europe Vitrectomy Devices Market would witness market growth of 5.6% CAGR during the forecast period (2021-2027).
Vision loss is among the leading health problems across the aging population. Moreover, age-related cataracts, glaucoma, macular degeneration, and diabetic retinopathy are some of the other main causes of vision loss. The surge in the occurrence of eye-related disorders is slowly boosting the demand for retina health care programs and surgeries among the geriatric population accelerating the demand for sophisticated vitrectomy devices. Diabetes is among the major causes of visual impairment among older consumers.
According to the NCBI article published in July 2021, the number of hospitals admission for Rhegmatogenous Retinal Detachment (RRD) is constantly growing in the UK since 2000. According to the HES Hospital Admitted Patient Care Activity records, a significant number of patients are admitted for RRD, hence augmenting the demand for pars plana vitrectomy procedures. Hence, to cater to this increasing demand, key market players are displaying developments in retina space in conferences to boost its reach and adoption.
The increasing adoption rate of vitreoretinal surgery devices in vitrectomy and the presence of major manufacturers in different developed countries of this region are expected to create new growth avenues for the players operating in the European vitrectomy devices market during the forecasting period.
Key regional markets in the regional vitrectomy devices market are focusing on launching innovative and sophisticated products for the treatment of retina care and increasing the adoption of vitrectomy for treating retinal detachment. The growth of the regional market is further driven by the favorable insurance policies, the surge in occurrence of eye-related diseases in the region, and increasing product approvals for different eye diseases would boost the demand & growth of vitrectomy devices in the regional market. Hence, all these aspects would collectivity propel the growth of regional vitrectomy devices during the forecast period.
The Germany market dominated the Europe Illumination Devices Market by Country in 2020, thereby, achieving a market value of $16.6 million by 2027. The UK market is exhibiting a CAGR of 5.8% during (2021 - 2027). Additionally, The France market is anticipated to witness a CAGR of 8.2% during (2021 - 2027).
Based on Application, the market is segmented into Vitreous hemorrhage, Macular hole, Diabetic retinopathy, Retinal detachment, and Other Applications. Based on Product, the market is segmented into Vitrectomy Machines, Illumination Devices, Photocoagulation Lasers and Vitrectomy Packs. Based on End Use, the market is segmented into Ophthalmology clinics, Hospitals and Ambulatory Surgical Centers. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Vitrectomy Devices Market Size will Hit $1.5 Billion by 2027, at a CAGR of 6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bausch Health Companies, Inc., Carl Zeiss AG, Johnson & Johnson, Topcon Corporation, Hoya Corporation, Alcon, Inc., Beaver-Visitec International, Inc. (TPG Capital), Blink Medical Ltd. (Katena Products, Inc.), Nidek Co., Ltd., and Lumenis Ltd.
By Application
By Product
By End Use
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 